Article de revue
Economic impact of pneumococcal protein-D conjugate vaccine (PHiD-CV) on the Malaysian National Immunization Programme
This study assesses the cost-effectiveness of introducing pneumococcal polysaccharide and nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in the National Immunization Programme of Malaysia. It compares introducing PHiD-CV (10 valent vaccine) with current no vaccination, as well as against the alternative 13-valent pneumococcal conjugate vaccine (PCV13).
Auteurs
Langues
- Anglais
Année de publication
2014
Journal
Value in Health Regional Issues
Volume
3
Type
Article de revue
Catégories
- Prestation de services
Maladies
- HIB
Pays
- Malaisie
Mots-clés
- Introduction de nouveaux vaccins
- Planification, budgétisation et financement
Régions de l'OMS
- Région du Pacifique occidental